跳至主要内容
临床试验/CTRI/2021/04/033060
CTRI/2021/04/033060招募中3 期

Comparison Of Low Vs High Dose 177Lu-EDTMP Therapy For Palliation Of Painful Bone Metastases: RCT.

AIIMS Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
AIIMS Jodhpur

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with greater than 18 years of age, with HPE confirmed cancer.
  • 2. Patients having painful metastatic bone lesions with osteoblastic response, as confirmed by areas of intense uptake on radionuclide bone scans at painful sites.
  • 3.The patients on naive or prior analgesic therapy.
  • 4.The minimum VAS/NRS score without medication should be > 4.
  • 5.The patientâ??s KPS score should be > 30 and ECOG < 3.
  • 6.Time interval between 177Lu-EDTMP therapy and prior chemotherapy or radiotherapy should be greater than four weeks.

排除标准

  • 1.Patients with the following cell count limits will not be considered for the therapy:
  • Haemoglobin < 9 g/dL
  • Total white cell count < 3000/μL
  • Platelet count < 60000/μL
  • 2.Patients with poor renal function i.e. estimated glomerular filtration rate < 30 mL/ min.
  • 3.Patients with life expectancy less than 3 months.
  • 4.Pregnant or lactating females if any.

研究者

发起方
AIIMS Jodhpur

相似试验